摘要:
MT-SP1 mutein proteases with altered specificity for the target molecules they cleave can be used to treat human diseases, such as cancer. Cleaving VEGF or VEGFR at certain substrate sequences with wild-type and mutein MT-SP1 proteases can be used to treat pathologies associated with angiogenesis.
摘要:
Provided are methods for and compounds for modulating the complement system. In particular, compounds are provided that inhibit complement activation and compounds are provided that promote complement activation. The compounds are therapeutics by virtue of their effects on the complement system. Hence, the compounds that inhibit complement activation can be used for treatment of ischemic and reperfusion disorders, including myocardial infarction and stroke, sepsis, autoimmune diseases, inflammatory diseases and diseases with an inflammatory component, including Alzheimer's Disease and other neurodegenerative disorder.
摘要:
A toilet refill restrictor apparatus includes an adapter interposed between a fill valve and a refill hose. The adapter is non-removably coupled to the fill valve and is configured with a larger proximal pathway, and a smaller distal metering pathway for restricting the refill flow rate. The adapter may be coupled to a shortened horizontal outlet formed at a top portion of the fill valve. The horizontal outlet is shortened to a length such that the refill hose cannot be connected directly to the outlet. The adapter may also be coupled to a fill valve without a horizontal outlet where an exit port is defined in the vertical conduit of the fill valve. The adapter includes a securing mechanism to prevent removal from the fill valve without excessive force or breaking the adapter.
摘要:
Disclosed herein are methods for generating proteases with altered specificity for the target molecules they cleave. The invention further discloses methods of using these proteases to treat diseases in which the target proteins are involved with. Cleaving certain target proteins at certain substrate sequences with a protease is a method for treating these pathologies.
摘要:
Provided are methods for and compounds for modulating the complement system. In particular, compounds are provided that inhibit complement activation and compounds are provided that promote complement activation. The compounds are therapeutics by virtue of their effects on the complement system. Hence, the compounds that inhibit complement activation can be used for treatment of ischemic and reperfusion disorders, including myocardial infarction and stroke, sepsis, autoimmune diseases, inflammatory diseases and diseases with an inflammatory component, including Alzheimer's Disease and other neurodegenerative disorder.